Quadratus Lumborum Block for Abdominoplasty

Summary

Double blinded, randomized, controlled, phase IV intervention trial. Both groups will receive a quadratus lumborum Block (QL), using ropivacaine 3.75 mg/mL in the intervention group, and sterile sodium chloride in the control group. The aim of study is to investigate the effect of a QL Block on the perioperative pain during postbariatric abdominoplasty.

Timeline

Start

2016-11-07

Primary completion

2017-06-15

Completion

2017-12-13

Drugs

Indications